Follow-up after successful endoscopic therapy for early Barrett's neoplasia: Is it time to talk money yet?
- PMID: 36262508
- PMCID: PMC9576328
- DOI: 10.1055/a-1931-3841
Follow-up after successful endoscopic therapy for early Barrett's neoplasia: Is it time to talk money yet?
Conflict of interest statement
Competing interests R.E. Pouw: Consultancy for Medtronic and Mircotech. Other authors declare that they have no conflict of interest.
Comment on
-
Comparative cost-effectiveness of three post-radiofrequency ablation surveillance intervals for Barrett's esophagus.Endosc Int Open. 2022 Aug 15;10(8):E1053-E1064. doi: 10.1055/a-1858-0945. eCollection 2022 Aug. Endosc Int Open. 2022. PMID: 35979029 Free PMC article.
References
-
- Wolfson P, Ho K MA, Wilson A et al.Endoscopic eradication therapy for Barrett’s esophagus–related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry. Gastrointest Endosc. 2022;96:223–233. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
